Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation.

Abstract : The correlation between the incidence of GVHD and the number of infused CD34(+) cells remains controversial for PBSC transplantation after a reduced-intensity-conditioning (RIC) regimen. We evaluated 99 patients transplanted with an HLA-identical sibling after the same RIC (2-Gy-TBI/fludarabine). Donor and recipient characteristics, donor's blood G-CSF-mobilized CD34(+) cell count, and number of infused CD34(+) and CD3(+) cells were analyzed as risk factors for acute and chronic GVHD There was a trend for an increased incidence of extensive chronic GVHD in the quartile of patients receiving more than 10 × 10(6) CD34(+) cells/kg (P = 0.05). Interestingly, the number of donor's blood CD34(+) cells at day 5 of G-CSF mobilization was closely associated with the incidence of extensive chronic GVHD, that is, 48% (95% CI: 28-68) at 24-months in the quartile of patients whose donors had the highest CD34(+) cell counts versus 24.3% (95% CI: 14-34) in the other patients (P = 0.007). In multivariate analysis, the only factor correlating with extensive chronic GVHD (cGVHD) was the donor's blood CD34(+) cell count after G-CSF (HR 2.49; 95% CI: 1.16-5.35, P = 0.019). This study shows that the incidence of cGVHD is more strongly associated with the donor's ability to mobilize CD34(+) cells than with the number of infused CD34(+) cells.
Type de document :
Article dans une revue
Bone Marrow Transplantation, Nature Publishing Group, 2012, 47 (12), pp.1564-8. 〈10.1038/bmt.2012.75〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00821516
Contributeur : Philippe Saas <>
Soumis le : vendredi 10 mai 2013 - 15:39:28
Dernière modification le : mercredi 20 juin 2018 - 11:54:03

Lien texte intégral

Identifiants

Collections

Citation

Nathalie Dhédin, Thomas Prébet, Régis Peffault de Latour, Sandrine Katsahian, Mathieu Kuentz, et al.. Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation.. Bone Marrow Transplantation, Nature Publishing Group, 2012, 47 (12), pp.1564-8. 〈10.1038/bmt.2012.75〉. 〈inserm-00821516〉

Partager

Métriques

Consultations de la notice

333